Descrizione

The global botulinum toxin market is poised to grow by US$ 3.4 miliardi da 2022 A 2028, registrando un CAGR di 7.8% durante il periodo di previsione, secondo StrategyHelix.

Il rapporto fornisce dati aggiornati sulle dimensioni del mercato per il periodo 2018-2021 e previsione a 2028 covering key market aspects like sales value for botulinum toxin. The global botulinum toxin market is segmented on the basis of product, applicazione, end user, e regione. Per prodotto, the global botulinum toxin market has been segmented into type A botulinum toxin, type B botulinum toxin. Based upon application, the global botulinum toxin market is categorized into aesthetic, medical. In base all'utente finale, the global botulinum toxin market has been segmented into hospitals, specialty and dermatology clinics, altri. In termini di geografia, the global botulinum toxin market has been segmented into Asia Pacific, Europa, Nord America, Rest of the World (RoW).

The aesthetic application market is further segmented into forehead lines, glabellar lines, lateral canthal lines (crow’s feet), e altri. Inoltre, the medical application market has been categorized into chronic migraine, hyperhidrosis, muscle spasm, over reactive bladder, e altri.

The global botulinum toxin market is highly competitive. Some of the leading companies operating in the market are AbbVie Inc. (Allergan plc), Daewoong Pharmaceutical Co. Ltd., Evolus Inc., Galderma S.A., HUGEL Inc., Ipsen S.A., Lanzhou Institute of Biological Products Co. Ltd., Medy-Tox Inc., Merz Pharma GmbH & Co. KGaA, Revance Therapeutics Inc., US WorldMeds LLC.

Il rapporto è una risorsa inestimabile per le aziende e le organizzazioni attive in questo settore. It provides a cohesive picture of the botulinum toxin market to help drive informed decision making for industry executives, decisori politici, accademico, e analisti.

Ambito del rapporto

Prodotto: type A botulinum toxin, type B botulinum toxin
Applicazione: aesthetic, medical
Utente finale: ospedali, specialty and dermatology clinics, altri
Regione: Asia Pacifico, Europa, Nord America, Rest of the World (RoW)
Anni considerati: la presente relazione copre il periodo 2018 A 2028

Principali vantaggi per gli stakeholder

– Get a comprehensive picture of the global botulinum toxin market
– Individuare i settori in crescita e le tendenze per gli investimenti

Sommario

Parte 1. introduzione
– Ambito dello studio
– Periodo di studio
– Ambito geografico
– Metodologia di ricerca
Parte 2. Botulinum toxin market overview
Parte 3. Ripartizione del mercato per prodotto
– Type A botulinum toxin
– Type B botulinum toxin
Parte 4. Market breakdown by application
– Aesthetic
– Medical
Parte 5. Market breakdown by end user
– Ospedali
– Specialty and dermatology clinics
– Altri
Parte 6. Market breakdown by region
– Asia Pacifico
– Europa
– Nord America
– Rest of the World (RoW)
Parte 7. Aziende chiave
– AbbVie Inc. (Allergan plc)
– Daewoong Pharmaceutical Co., Ltd.
– Evolus Inc.
– Galderma S.A.
– HUGEL Inc.
– Ipsen S.A.
– Lanzhou Institute of Biological Products Co., Ltd.
– Medy-Tox Inc.
– Merz Pharma GmbH & Co. KGaA
– Revance Therapeutics Inc.
– US WorldMeds LLC
Informazioni su StrategyHelix
Disclaimer